Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05287906 · ClinicalTrials.gov registry record · NA
A Trial to Assess Steviol Glycosides on Acute Appetite Hormone Release
A NA study of Type 2 Diabetes Mellitus and Overweight and Obesity, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
- Completed
- Registry status
- NA
- Development phase
- 69
- Enrollment target
- 3
- Study locations
NCT05287906 is a NA study of Type 2 Diabetes Mellitus and Overweight and Obesity that has completed, run by Midwest Center for Metabolic and Cardiovascular Research. The registered enrollment target is 69 participants, below the 2,748-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT05287906, a NA study of Type 2 Diabetes Mellitus and Overweight and Obesity, has completed, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
- 3
- Study locations
Study Summary
The objectives of this trial are to assess the effects of steviol glycoside alone or in combination with a glycemic carbohydrate on blood glucose and endocrine and gut hormone secretion vs. water and glucose in individuals with normal weight, overweight and type 2 diabetes mellitus (T2DM).
Conditions Studied
Interventions
- OTHER Water
- OTHER Glucose
- OTHER Steviol Glycosides
- OTHER Steviol Glycosides plus glucose
- OTHER Rebaudioside A
Study Locations (3)
Florida
- Excellence Medical and Research - Miami Gardens
- Advanced Research for Health Improvement - Naples
Illinois
- Great Lakes Clinical Trials - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2022-04-15 |
| Est. Completion | 2024-06-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05287906
The ClinicalTrials.gov registry entry for NCT05287906 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,748-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (97% lower). The listed sponsor is Midwest Center for Metabolic and Cardiovascular Research, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 5 interventions - of which Water is the first listed.
NCT05287906 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT05287906 about?
NCT05287906 is a clinical study titled "A Trial to Assess Steviol Glycosides on Acute Appetite Hormone Release". The objectives of this trial are to assess the effects of steviol glycoside alone or in combination with a glycemic carbohydrate on blood glucose and endocrine and gut hormone secretion vs. water and glucose in individuals with normal weight, overweight and type 2 diabetes mellitus (T2DM).
What is the current status of trial NCT05287906?
This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2022-04-15. Estimated completion is 2024-06-05.
What conditions does trial NCT05287906 study?
This clinical trial studies the following conditions: Type 2 Diabetes Mellitus, Overweight and Obesity.
What interventions are being tested in trial NCT05287906?
The interventions under investigation include: Water (OTHER), Glucose (OTHER), Steviol Glycosides (OTHER), Steviol Glycosides plus glucose (OTHER), Rebaudioside A (OTHER).
Who is sponsoring clinical trial NCT05287906?
This trial is sponsored by Midwest Center for Metabolic and Cardiovascular Research, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05287906 being conducted?
This trial has 3 study locations across Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Preventing Type 2 Diabetes in Black Emergent Adult
RECRUITING · NA
-
The GRoceries Aimed at Increasing Nutrition Study
RECRUITING · NA
-
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
RECRUITING · NA
-
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes
RECRUITING · NA
-
Impact of Metabolic Health on Sperm Epigenetic Marks in Humans
ACTIVE NOT RECRUITING · NA
-
Is the Degree of Perceived Effort During Resistance Exercise Important for Improvements in Blood Glucose
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.